-
-
-
-
-
-
-
Novartis (NVS) Acquisition of AveXis (AVXS) is Incremental Negative for Biogen (BIIB) - UBS
-
-
-
-
-
-
-
AveXis (AVXS) Prices 3.92M Share Common Offering at $102/Sh
-
-
-
-
-
-
-
AveXis (AVXS): Type 2 SMA Opportunity Could Be Larger Than Expected - Jefferies
-
-
-
-
-
-
-
AveXis (AVXS): AVXS-101 Abstracts Could Highlight The Next Driver - BMO
-
-
-
-
-
-
-
AveXis (AVXS) Announces Alignment with FDA on GMP for AVXS-10 Manufacturing
-
-
-
-
-
-
-
AveXis (AVXS) Adds to Early Gains Amid Promising SMA Trial Data
-
-
-
-
-
-
-
AveXis (AVXS) PT Raised to $100 at Chardan Capital Markets
-
64,524 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

